Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

POINT CAPITAL INC

Delayed Other OTC  -  01:13:43 2019-07-16 pm EDT
0.5500 USD   +37.50%
02/02Silo Pharma Secures US Patent for SPC-15 in Treatment of Stress-Induced Affective Disorder
MT
02/02Silo Pharma Announces Expansion of Intellectual Property Portfolio
GL
01/31Sector Update: Health Care Stocks Add to Earlier Gains
MT
SummaryChartsNewsCompanyFunds 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about POINT CAPITAL INC
02/02Silo Pharma Secures US Patent for SPC-15 in Treatment of Stress-Induced Affective Disor..
MT
02/02Silo Pharma Announces Expansion of Intellectual Property Portfolio
GL
01/31Silo Pharma, Inc. announces an Equity Buyback for $1 million worth of its shares.
CI
01/31Silo Pharma Board Authorizes $1 Million Share Buyback Plan; Stock Rises
MT
01/31Silo Pharma Announces Stock Repurchase Program
GL
01/31Silo Pharma, Inc. authorizes a Buyback Plan.
CI
01/10Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
GL
01/10Silo Pharma, Inc. Advances Clinical Study Analyzing Effects of Psilocybin on Inflammati..
CI
2022Silo Pharma Says Animal Study Interim Data Shows SPU-21 is Effective in Controlling Art..
MT
2022Silo Pharma Announces Positive Study Results of SPU- 21 for Arthritis
GL
2022Silo Pharma Announces Positive Study Results of SPU- 21 for Arthritis
CI
2022Silo Pharma, Inc.(NasdaqCM:SILO) added to S&P TMI Index
CI
2022Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combini..
GL
2022Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human Tissue
GL
2022Silo Pharma, Inc. Initiates Study of Novel Joint Homing Peptide in Human Tissue
CI
More most relevant news
All news about POINT CAPITAL INC
02/02Silo Pharma Secures US Patent for SPC-15 in Treatment of Stress-Induced Affective Disor..
MT
02/02Silo Pharma Announces Expansion of Intellectual Property Portfolio
GL
01/31Sector Update: Health Care Stocks Add to Earlier Gains
MT
01/31Silo Pharma, Inc. announces an Equity Buyback for $1 million worth of its shares.
CI
01/31Sector Update: Health Care Stocks Advancing Tuesday Afternoon
MT
01/31Silo Pharma Board Authorizes $1 Million Share Buyback Plan; Stock Rises
MT
01/31Silo Pharma Announces Stock Repurchase Program
GL
01/31Silo Pharma, Inc. authorizes a Buyback Plan.
CI
01/10Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
GL
01/10Silo Pharma, Inc. Advances Clinical Study Analyzing Effects of Psilocybin on Inflammati..
CI
More news
News in other languages on POINT CAPITAL INC
02/02Silo Pharma décroche un brevet américain pour le SPC-15 dans le traitement des troubles..
01/31Mise à jour sectorielle : Les actions du secteur de la santé ajo..
01/31Silo Pharma, Inc. (NasdaqCM:SILO) annonce un rachat d'action..
01/31Mise à jour sectorielle : Les actions du secteur de la santé pro..
01/31Le conseil d'administration de Silo Pharma autorise un plan de rachat d'actions d'un mi..
01/31Silo Pharma, Inc. autorise un plan de rachat.
01/10Silo Pharma, Inc. fait avancer l'étude clinique analysant les effets de la psilocybine ..
2022Silo Pharma affirme que les données provisoires d'une étude sur les animaux montrent qu..
2022Silo Pharma annonce les résultats positifs d'une étude sur le SPU- 21 pour l'arthrite
2022Silo Pharma, Inc. lance l'étude d'un nouveau peptide de localisation des articulations ..
More news
Press releases
02/02Silo Pharma Announces Expansion of Intellectual Property Portfolio
GL
01/31Silo Pharma Announces Stock Repurchase Program
GL
01/10Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
GL
2022Silo Pharma Announces Positive Study Results of SPU- 21 for Arthritis
GL
2022Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combini..
GL
More press releases